MOG (35-55) (TFA)

OC(C(F)(F)F)=O.O=C([C@@H](N)CCSC)N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(O)=O)CCCCN)=O)=O)CC(N)=O)=O)CCCNC(N)=N)=O)CC2=CC=C(O)C=C2)=O)CC(C)C)=O)CC3=CNC=N3)=O)C(C)C)=O)C(C)C)=O)CCCNC(N)=N)=O)CO)=O)CC4=CC=CC=C4)=O)CCC1)=O)CO)=O)CCCNC(N)=N)=O)CC5=CC=C(O)C=C5)=O)CC6=CNC7=CC=CC=C67)=O)=O)C(C)C)=O)CCC(O)=O

[1]Rich C, et, al. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Eur J Immunol. 2004 May;34 (5) :1251-61.|[2]Slavin A, et, al. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity. 1998;28 (2) :109-20.|[3]Giralt M, et, al. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG35-55 in the Mouse. Methods Mol Biol. 2018;1791:227-232.

Acta Physiol. 2023 Jun;238 (2) :e13974.|Adv Sci (Weinh) . 2025 Jan 13:e2409086.|Cell Death Dis. 2022 Sep 2;13 (9) :759.|Int Immunopharmacol. 2022 Apr:105:108566.|Cornell University. 2025.|EMBO Mol Med. 2025 Sep 29.|Front Biosci (Landmark Ed) . 2025 May 23;30 (5) :37838.|Mol Biol Rep. 2025 Nov 15;53 (1) :92.|Research Square Print. September 28th, 2022.